Trial of Nivolumab With Chemotherapy as Neoadjuvant Treatment in Inflammatory Breast Cancer (IBC)
Clinical trial NCT03742986 · COMPLETED
Trial details
- NCT number
- NCT03742986
- Sponsor
- NYU Langone Health
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-02
- Primary completion
- 2023-06-12
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.